3 Reasons to Avoid CLOV and 1 Stock to Buy Instead
SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health”...
1 Unprofitable Stock for Long-Term Investors and 2 We Ignore
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of...
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Ignore
WILMINGTON, Del., March 04, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed...
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth...
Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect
1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges